Our aim is simple – to be distinguished by our academic strengths and recognised globally for the social, economic and cultural benefit we deliver through our research.
Search Our Research
Our Faculties, Schools and Clusters
View the research profile of our faculties, schools and research clusters.
Search our Research Publications
50,000+ research outputs with links to DOIs and open access full text when available.
Search for our Research Staff
View the research profiles for all our researchers.
See the Impact of our Research
See the impact of our research in society.
Our REF2014 results
Queen’s returned over 95% of academic staff, which was the fifth largest percentage of staff returned in the REF2014. The University also has 14 subject areas ranked within the UK’s Top 20 and 76% of its research classified in the top two categories of world leading and internationally excellent.
Our European Union Projects
View our latest Horizon 2020 Projects
Queen’s has coordinated about 50 projects and been involved in 90 other projects under the 7th Framework Programme. In Horizon 2020, Queen’s has already secured 30 new grants.
We are delighted to welcome our Queen’s Fellows
The appointments have been made as part of the prestigious Queen’s University Research Fellowship Scheme which aims to attract, retain and develop the very best of research talent.
Forthcoming & Latest Publications
- CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial
- An overview on personalisation of radiotherapy prescriptions in locally advanced non-small cell lung cancer: Are we there yet?: 2018 Jun 13. pii: S0167-8140(18)30288-3. doi: 10.1016/j.radonc.2018.05.029. [Epub ahead of print]
- IMMUNOTHERAPY FOR LUNG CANCER – A GAME CHANGER!
- A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424.
- Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial.
- Genomic Profiling of Small Bowel Adenocarcinoma: Insights from a Comparative Analysis with Gastric and Colorectal Cancer.
- Time for reparations for victims of conflict-related sexual violence
- The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia
- Modelling pulmonary microthrombosis coupled to metastasis: distinct effects of thrombogenesis on tumorigenesis
- Metabolic basis to Sherpa altitude adaptation